Pretherapeutic estimated glomerular filtration rate predicts development of chronic kidney disease in patients receiving PSMA-targeted radioligand therapy.
Liam WidjajaThorsten DerlinTobias L RossFrank M BengelRudolf A WernerPublished in: The Prostate (2021)
Serious adverse renal events are not a frequent phenomenon after PSMA-targeted RLT. However, in patients developing moderate CKD after RLT, pretherapeutic eGFR is an independent predictor for renal impairment during follow-up.
Keyphrases
- chronic kidney disease
- end stage renal disease
- pet ct
- peritoneal dialysis
- small cell lung cancer
- pet imaging
- ejection fraction
- cancer therapy
- newly diagnosed
- prognostic factors
- tyrosine kinase
- stem cells
- drug delivery
- high intensity
- mesenchymal stem cells
- electronic health record
- positron emission tomography
- smoking cessation